ZFIN ID: ZDB-FISH-150901-11558
Fish name: gli2aty119/ty119
Genotype: gli2aty119/ty119
Targeting Reagent: none
HUMAN DISEASE MODELED by gli2aty119/ty119
No data available
GENE EXPRESSION
Gene expression in gli2aty119/ty119
RNA expression
Expressed Gene Structure Conditions Figures
alcama standard conditions Fig. 1 with imageFig. 5 with image from Vanderlaan et al., 2005
dlx2a standard conditions Fig. 1 with image from Bergeron et al., 2011
efemp2a standard conditions Fig. 7 with image from Wang et al., 2013
egr2b standard conditions Fig. 2 with imageFig. 3 with imageFig. 5 with imageFig. 6 with imageFig. 10 with image from Vanderlaan et al., 2005
chemical treatment: Cyclopamine Fig. 2 with image from Vanderlaan et al., 2005
en1a standard conditions Fig. 4 with image from Ochi et al., 2006
Fig. 4 from Kawakami et al., 2005
flt4 standard conditions text only from Lawson et al., 2002
foxe3 standard conditions Fig. 3 from Swindell et al., 2008
fras1 standard conditions Fig. 7 with image from Wang et al., 2013
gfap standard conditions Fig. 4 with imageFig. 5 with imageFig. 6 with image from Barresi et al., 2005
gh1 standard conditions Fig. S2 with image from Bergeron et al., 2011
gli2a standard conditions Fig. 8 with image from Vanderlaan et al., 2005
hhip standard conditions Fig. S1 with image from Ochi et al., 2006
hnmt standard conditions Fig. 7 with image from Wang et al., 2013
isl1 standard conditions Fig. 8 with image from Vanderlaan et al., 2005
lamc1 standard conditions Fig. 7 with image from Wang et al., 2013
lrp4 standard conditions Fig. 7 with image from Wang et al., 2013
myl10 standard conditions Fig. 7 with image from Wang et al., 2013
myod1 standard conditions Fig. 4 with image from Wang et al., 2013
Fig. 6 with image from Groves et al., 2005
Fig. 8 with image from Karlstrom et al., 2003
Fig. 1 with imageFig. 3 with image from Lewis et al., 1999
Fig. 1 from van Eeden et al., 1998
Fig. 9 with image from van Eeden et al., 1996
chemical treatment: SU5402 Fig. 6 with image from Groves et al., 2005
nkx2.1 standard conditions Fig. 9 with image from Karlstrom et al., 2003
nkx2.2a standard conditions Fig. 2 with image from Wang et al., 2013
Fig. 2 with imageFig. 3 with imageFig. 5 with imageFig. 8 with image from Vanderlaan et al., 2005
text only from Sekimizu et al., 2004
Fig. 1 with imageFig. 8 with image from Karlstrom et al., 2003
Fig. 5 from Karlstrom et al., 1999
chemical treatment: Cyclopamine Fig. 2 with image from Vanderlaan et al., 2005
nr5a2 standard conditions Fig. 3 with image from Sheela et al., 2005
nrp1a standard conditions Fig. 6 with image from Sato-Maeda et al., 2006
ntn1a standard conditions Fig. 2 with imageFig. 3 with imageFig. 6 with image from Vanderlaan et al., 2005
olig2 standard conditions Fig. 2 with imageFig. 6 with image from Wang et al., 2013
pax6a standard conditions text only from Sekimizu et al., 2004
Fig. 1 with image from Karlstrom et al., 2003
Fig. 5 from Karlstrom et al., 1999
pomca standard conditions Fig. S2 with image from Bergeron et al., 2011
prdm1a standard conditions Fig. 2 with image from Wang et al., 2013
prdm8b standard conditions Fig. 7 with image from Wang et al., 2013
prl standard conditions Fig. S2 with image from Bergeron et al., 2011
ptch2 standard conditions Fig. 2 with image from Wang et al., 2013
Fig. 2 with imageFig. 10 with image from Vanderlaan et al., 2005
Fig. 1 with imageFig. 8 with image from Karlstrom et al., 2003
Fig. 5 from Karlstrom et al., 1999
Fig. 1 with imageFig. 3 with imageFig. 4 with image from Lewis et al., 1999
quo standard conditions Fig. 7 with image from Wang et al., 2013
sema3d standard conditions Fig. 5 with image from Barresi et al., 2005
sema3h standard conditions Fig. 2 with image from Stevens et al., 2005
shha standard conditions Fig. 5 from Karlstrom et al., 1999
slit1a standard conditions Fig. 1 with image from Bergeron et al., 2011
Fig. 5 with image from Barresi et al., 2005
slit2 standard conditions Fig. 1 with image from Bergeron et al., 2011
Fig. 5 with image from Barresi et al., 2005
slit3 standard conditions Fig. 5 with image from Barresi et al., 2005
smyd1b standard conditions Fig. 6 with image from Du et al., 2006
tp73 standard conditions Fig. 4 with image from Rentzsch et al., 2003
vegfaa standard conditions text only from Lawson et al., 2002
wnt4b standard conditions Fig. 3 from Liu et al., 2000
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab-EB165 standard conditions Fig. 5 with image from Lewis et al., 1999
znp-1 standard conditions Fig. 5 with image from van Eeden et al., 1996
Ab1-smyhc standard conditions Fig. 5 with image from Lewis et al., 1999
zn-5 standard conditions Fig. 7 from Brand et al., 1996
Ab1-eng standard conditions Fig. 7 from Wolff et al., 2003
Fig. 9 with image from van Eeden et al., 1996
Ab-F59 standard conditions Fig. 6 with image from Lobbardi et al., 2011
Reporter gene expression No data available
PHENOTYPE
Phenotype in gli2aty119/ty119
Phenotype Conditions Figures
adaxial cell absent, abnormal standard conditions Fig. 1 from van Eeden et al., 1998
Fig. 9 with image from van Eeden et al., 1996
adenohypophysis aplastic, abnormal standard conditions Fig. 3 from Swindell et al., 2008
anterior commissure decreased size, abnormal standard conditions Fig. 4 from Karlstrom et al., 1999
blood circulation disrupted, abnormal standard conditions Table 1 from Chen et al., 1996
Fig. 8 with image from van Eeden et al., 1996
brain quality, abnormal standard conditions Fig. for (ty119) with image from Phenotype Annotation (1994-2006)
CaP motoneuron axon decreased amount, abnormal standard conditions Fig. 5 with image from van Eeden et al., 1996
cell migration involved in kidney development disrupted, abnormal standard conditions Fig. 2 with image from Majumdar et al., 2000
central nervous system projection neuron axonogenesis disrupted, abnormal standard conditions Fig. 5 with image from van Eeden et al., 1996
ceratobranchial 5 bone decreased length, abnormal standard conditions Fig. 4 with image from Wiweger et al., 2012
ceratobranchial 5 bone has fewer parts of type ceratobranchial 5 tooth, abnormal standard conditions Fig. 4 with image from Wiweger et al., 2012
ceratobranchial 5 tooth decreased length, abnormal standard conditions Fig. 4 with image from Wiweger et al., 2012
ceratobranchial 5 tooth increased width, abnormal standard conditions Fig. 4 with image from Wiweger et al., 2012
chondrocranium morphology, abnormal standard conditions Table 2 from Piotrowski et al., 1996
cranial neural crest cell mislocalised ventrally, abnormal standard conditions Table 2 from Piotrowski et al., 1996
esophageal epithelium disorganized, abnormal standard conditions Fig. 9 with image from Wallace et al., 2003
esophageal epithelium epithelial cell differentiation disrupted, abnormal standard conditions Fig. 9 with image from Wallace et al., 2003
esophagus malformed, abnormal standard conditions Fig. 9 with image from Wallace et al., 2003
ethmoid cartilage aplastic, abnormal standard conditions Fig. 8 from Brand et al., 1996
eye decreased distance eye, abnormal standard conditions Fig. 2 from Brand et al., 1996
Fig. 8 with image from van Eeden et al., 1996
eye mislocalised medially, abnormal standard conditions Fig. 2 from Brand et al., 1996
fast muscle cell absent, abnormal standard conditions Fig. 7 from Wolff et al., 2003
floor plate hypoplastic, abnormal standard conditions Table 1 from Brand et al., 1996
forebrain physical object quality, abnormal standard conditions Fig. 1 with image from Bergeron et al., 2011
forebrain regionalization process quality, abnormal standard conditions Fig. 1 with image from Bergeron et al., 2011
horizontal myoseptum absent, abnormal standard conditions Fig. 2 from van Eeden et al., 1998
horizontal myoseptum aplastic, abnormal standard conditions Fig. 8 with image from van Eeden et al., 1996
larval locomotory behavior process quality, abnormal standard conditions Table 4 from Granato et al., 1996
lens increased amount, abnormal standard conditions Fig. 3 from Swindell et al., 2008
lens mislocalised, abnormal standard conditions Fig. 3 from Swindell et al., 2008
MiP motor neuron axon decreased amount, abnormal standard conditions Fig. 5 with image from van Eeden et al., 1996
muscle cell differentiation decreased occurrence, abnormal standard conditions Fig. 6 with image from Lobbardi et al., 2011
muscle pioneer absent, abnormal standard conditions Fig. 6 with image from Lobbardi et al., 2011
Fig. 7 from Wolff et al., 2003
musculoskeletal movement quality, abnormal standard conditions Fig. for (ty119) with image from Phenotype Annotation (1994-2006)
myoseptum aplastic, abnormal standard conditions Table 1 from Brand et al., 1996
nervous system quality, abnormal standard conditions Fig. for (ty119) with image from Phenotype Annotation (1994-2006)
neural tube quality, abnormal standard conditions Fig. for (ty119) with image from Phenotype Annotation (1994-2006)
optic chiasm absent, abnormal standard conditions Fig. 4 from Karlstrom et al., 1999
optic chiasm malformed, abnormal standard conditions Fig. 7 from Brand et al., 1996
optic nerve formation disrupted, abnormal standard conditions Fig. 4 from Karlstrom et al., 1999
pericardium edematous, abnormal standard conditions Fig. 8 with image from van Eeden et al., 1996
pharyngeal arch 3-7 mislocalised ventrally, abnormal standard conditions Fig. 8 with image from van Eeden et al., 1996
post-vent region curved, abnormal standard conditions Fig. 8 with image from van Eeden et al., 1996
post-vent region curved ventral, abnormal standard conditions Fig. 1 with image from Schwend et al., 2010
Table 1 from Brand et al., 1996
postoptic commissure absent, abnormal standard conditions Fig. 4 from Karlstrom et al., 1999
proctodeum atretic, abnormal standard conditions Fig. 3 with image from Parkin et al., 2009
proctodeum malformed, abnormal standard conditions Fig. 3 with image from Parkin et al., 2009
pronephric glomerulus increased amount, abnormal standard conditions Fig. 2 with image from Majumdar et al., 2000
pronephric glomerulus mislocalised laterally, abnormal standard conditions Fig. 2 with image from Majumdar et al., 2000
response to external stimulus quality, abnormal standard conditions Fig. for (ty119) with image from Phenotype Annotation (1994-2006)
retinal ganglion cell axon displaced to diencephalon, abnormal standard conditions Table 1 from Karlstrom et al., 1996
retinal ganglion cell axon ipsilateral to eye, abnormal standard conditions Table 1 from Karlstrom et al., 1996
retinal ganglion cell axon misrouted, abnormal standard conditions Table 1 from Karlstrom et al., 1996
retinal ganglion cell axon guidance disrupted, abnormal standard conditions Fig. 4 from Karlstrom et al., 1999
Fig. 7 from Brand et al., 1996
Table 3 from van Eeden et al., 1996
retinal ganglion cell axon guidance process quality, abnormal standard conditions Table 1 from Karlstrom et al., 1996
slow muscle cell absent, abnormal standard conditions Fig. 6 with image from Lobbardi et al., 2011
Fig. 2 from Du et al., 2001
smoothened signaling pathway decreased occurrence, abnormal standard conditions Fig. 6 with image from Lobbardi et al., 2011
somite lacks all parts of type muscle pioneer, abnormal standard conditions Fig. 9 with image from van Eeden et al., 1996
somite quality, abnormal standard conditions Fig. for (ty119) with image from Phenotype Annotation (1994-2006)
somite U-shaped, abnormal standard conditions Fig. 1 with image from Schwend et al., 2010
Fig. 1 with image from Karlstrom et al., 2003
striated muscle cell development arrested, abnormal standard conditions Fig. 2 from Du et al., 2001
third ventricle increased size, abnormal standard conditions Table 1 from Karlstrom et al., 1996
trabecula cranii fused with trabecula cranii, abnormal standard conditions Fig. 8 from Brand et al., 1996
whole organism curved ventral, abnormal standard conditions Fig. 1 with image from Karlstrom et al., 2003
whole organism decreased behavioural activity, abnormal standard conditions Table 4 from Granato et al., 1996
whole organism lethal (sensu genetics), abnormal standard conditions Fig. for (ty119) with image from Phenotype Annotation (1994-2006)
whole organism movement behavioral quality, abnormal standard conditions Table 1 from Brand et al., 1996
Table 3 from van Eeden et al., 1996

CITATIONS  (53)